Thu, January 23, 2020
Wed, January 22, 2020
Tue, January 21, 2020
Fri, January 17, 2020
Thu, January 16, 2020
Wed, January 15, 2020
Tue, January 14, 2020
Mon, January 13, 2020

David Lebovitz Maintained (ASND) at Buy with Increased Target to $148 on, Jan 17th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-148-on-jan-17th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $140 to $148 on, Jan 17th, 2020.

David has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $186 on, Tuesday, October 22nd, 2019

Publication Contributing Sources